Type 1 Diabetes Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are 18 years old or older
- You have been diagnosed with Type 1 diabetes or a slow-developing form of adult autoimmune diabetes (called LADA) for at least one year
- Your recent average blood sugar level (HbA1c) is above 8.0%, and your blood sugar levels vary a lot throughout the day as measured by a continuous glucose monitor (CGM)
- You are planning to start using one of the automated insulin delivery (AID) systems that are already available on the market
- You plan to use the fully automated ("closed-loop") mode of the device
- You are willing to share your CGM data with the research team during the study
Who may not be able to join:
- You are a woman who is pregnant, gave birth, or was breastfeeding less than 6 months before the study starts, or who plans to become pregnant during the study
- You have certain health conditions that affect bone health, such as advanced kidney disease, liver disease, celiac disease or other gut absorption problems, a history of organ transplant, active cancer, rheumatoid arthritis, or certain hormone disorders (confirm with trial site)
- You are expected to change your CGM sensor, insulin pump, or AID system during the study period
- You expect to need to take acetaminophen (e.g., Tylenol/paracetamol) at doses higher than 1g every 6 hours during the study
- You are currently taking or plan to take a medication called hydroxyurea
- You have taken certain medications in the past 12 months that affect bone health, including high-dose steroids, certain breast or prostate cancer treatments, blood thinners, or specific diabetes or osteoporosis medications (confirm with trial site for the full list)
- You are not able to give your informed consent to participate
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Rémi Rabasa-Lhoret, MD, PhD, IRCM
Phone: 514-987-5617
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Bone remodeling improvement
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.